Copenhagen, Denmark
Onsite/Online

ESTRO 2022

Session Item

Saturday
May 07
08:45 - 10:00
Auditorium 11
Soft tissue sarcoma: Brachytherapy and/or EBRT or IORT - Current evidence
Csaba Polgar, Hungary;
Vratislav Strnad, Germany
1120
Debate
Brachytherapy
08:47 - 09:07
Value of EBRT
Antonin Levy, France
SP-0030

Abstract

Value of EBRT
Authors:

Antonin Levy1, Cécile Le Péchoux1

1Gustave Roussy, Radiation Oncology, Villejuif, France

Show Affiliations
Abstract Text

Radiation therapy is a standard treatment for limbs soft tissue sarcomas. External-beam radiotherapy (EBRT) has been the most commonly used modality. Modern EBRT techniques such as conformal image-guided intensity modulated radiotherapy (IGRT/IMRT) could decrease the incidence of complications. Preoperative versus postoperative EBRT has been a controversial topic for years but the neoadjuvant schedule is henceforth gaining ground. Newer drug-EBRT combinations are also being prospectively assessed. EBRT must be personalized according to the histological subtype, the tumor site and the benefit/risk ratio, which is best appreciated by a multidisciplinary surgical and oncological team in a specialized center in the management of soft-tissue sarcomas.